Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
By Greg Norman for Fox News on November 26, 2024 The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic
Read MoreBy Greg Norman for Fox News on November 26, 2024 The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic
Read More(Juliette Cubanski for The Kaiser Family Foundation Published: Nov 19, 2024) The Inflation Reduction Act of 2022 (the Act), signed
Read More(By Fred Schulte for KFF Health News) A new federal watchdog audit is ratcheting up pressure on government officials to
Read More(By Fred Schulte for KFF Health News) A decade ago, federal officials drafted a plan to discourage Medicare Advantage health
Read More(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in
Read More(By Sydney Lupkin, Asma Khalid for NPR) The White House unveiled the fruits of months of negotiations between the government
Read More(By Ashleigh Hollowell for Becker’s Hospital Review) U.S. Sen. Tammy Baldwin, D-Wis., has introduced legislation that would shield communities from
Read More(By Rylee Wilson for Becker’s Hospital Review) HHS’ Office of Inspector General will audit Medicare Advantage plans’ use of prior
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS will extend flexibilities designed to help states keep more eligible individuals enrolled
Read More